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Abstract: A main objective of current medical research is to improve the life quality of elderly people as priority of the 
continuous increase of ageing population. This phenomenon implies several medical, economic and social problems be-
cause of dramatic increase in number of non autonomous individuals affected by various pathologies. Accordingly, the re-
search interest is focused on understanding the biological mechanisms involved in determining the positive ageing pheno-
type, i.e. the centenarian phenotype. In achieving this goal the choice of an appropriate study models is fundamental. Cen-
tenarians have been used as an optimal model for successful ageing. However, this model shows several limitations, i.e. 
the selection of appropriate controls and the use itself of the centenarians as a suitable model for healthy ageing. Thus, the 
interest has been centered on centenarian offspring, healthy elderly people. They may represent a model for understanding 
exceptional longevity for the following reasons: they exhibit a protective genetic background, cardiovascular and immu-
nological profile, as well as a reduced rate of cognitive decline than age-matched people without centenarian relatives. 
Several of these aspects are summarized in this review based on the literature and the results of our studies.  
Keywords: Ageing, cardiovascular profile, centenarians, centenarian offspring, genetic background, immunosenescence, mem-
ory decline.  
INTRODUCTION  
 Medical research is currently influenced by the massive 
ageing of the populations in the developed countries. This 
trend implies a set of medical, economic and social prob-
lems, principally caused by the increased number of not 
autonomous elderly individuals affected by several patholo-
gies. Thus, an improvement of human elderly health is re-
quired. This is leading the research interest to focus its atten-
tion on the so-called positive biology. It differs from well-
known current biology, which principally researches the 
causes of the chronic diseases, such as cardiovascular dis-
eases (CVD), cancer and Alzheimer disease (AD), today 
afflicting millions of people. In contrast, positive biology has 
a principal goal of identification of the biological mecha-
nisms characterising the positive phenotypes. In this contest, 
an interesting positive phenotype is given by exceptional 
individuals living long, showing relatively good health, able 
to perform their daily life tasks and to escape fatal age-
related diseases [1, 2]. The investigation of this particular 
positive phenotype, “phenotype of exceptional longevity”, 
can represent a remarkable study’s model of health and well-
being. This new study’s approach might provide useful data, 
whose translation might have several beneficial effects: from 
the modulation of ageing rate to the development of drugs or 
new lifestyle habits (i.e. a healthy diet, caloric uptake reduc-
tion, use of antioxidants, prebiotics and probiotics and  
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increased physical exercise) able in enhancing health and 
well-being, in retarding ageing and preventing or reducing 
frailty and disability especially in individuals genetically 
predisposed. Furthermore, this new study approach might 
provide evidence, which would further strengthen the con-
cepts of ageing theories [1, 2].  
 From this point of view, centenarian offspring (CO), 
healthy elderly people with a family history of longevity, 
may represent the most appropriate model for understanding 
exceptional longevity for several reasons. Firstly, they have a 
familial trait influenced principally by genetic factors and 
environmental conditions. Another reason is given by the 
possibility to obtain more applicable and reasonable findings 
than those achieved by investigations from laboratory ani-
mals, being different as organisms. Apart from differences in 
their genomes, development and life expectancy, the major 
difference between humans and laboratory animals is the 
quantity and quality of antigenic exposure. Typical labora-
tory organisms are usually housed in artificially clean envi-
ronments. Thus, they are underexposed to pathogens, or even 
completely protected from them, except for limited period of 
time required for experimental reasons. These animals are 
quite different from those living in the wild exposed to a 
plethora of different microorganisms, such as bacteria, vi-
ruses and parasites. Human beings have an environment, 
although controlled, not sterile, but rather full of microbes 
[3]. Some of them are normally hosted on skin and mucosal 
tissues, having a protective role against pathogenic microbes. 
In contrast, others are or can become pathogenic and trigger 
infectious diseases, which constituted a major life-
threatening event throughout the natural history of animal 
species. Furthermore, lifelong antigenic load and the conse-
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quent inflammation are assumed as the major determinants 
of human ageing rate and unsuccessful ageing.  
 Other interesting characteristics, such as a protective ge-
netic background, immunological profile and clinical history, 
seem to be exhibited by CO, when compared with age-
matched people without centenarian relatives. Many of these 
aspects are summarized in this review based on literature 
data and results of our studies.  
FOCUS ON CENTENARIANS OFFSPRING: FAVOR-
ABLE CARDIOVASCULAR RISK PROFILE 
 Several and comparable epidemiological studies in dif-
ferent populations (Ashkenazi Jews, Americans from New 
England, Japanese from Okinawa, Icelanders, Mormons, 
Netherlanders from Leiden) have established that the genetic 
component has a remarkable role in attaining longevity [4-9]. 
Siblings and CO, but not their spouses, show an increased 
odd ratio (OR) between 4- and 17-fold for longevity, when 
compared with appropriate controls [4, 5]. This supports the 
existence of strong genetic determinants for longevity. Fur-
thermore, it also suggests that the favorable modulation not 
only of ageing processes, but also of disease susceptibility, is 
strongly inherited in families with exceptional longevity. 
Thus, it supposes a possible transmission from centenarians 
to their descendants of the capacity to escape and/or post-
pone the major age-related diseases. In order to assess this, 
the interest has been centered on CO. On the other hand, 
their evaluation bypasses some problems, including the se-
lection of appropriate controls for centenarians, the elimina-
tion of the doubts to consider the centenarians as useful 
model for healthy ageing, since only few studies reported 
centenarians as healthier or well functioning during most of 
their lives compared with average populations [10-13].  
 The first data on CO have been obtained by the group of 
Perls and Terry, which analyzed in a cross-sectional study 
the prevalence of several age-related diseases in 177 CO and 
166 age-matched controls, without centenarian parents, en-
rolled in the nationwide New England Centenarian Study 
[14]. Like centenarians, CO had a markedly reduced risk for 
CVD (56%; OR 0.44, 95% CI 0.24-0.80), hypertension 
(66%; OR 0.34, 95% CI 0.21-0.55) and diabetes (59%; OR 
0.41, 95% CI 0.15-1.12), than age-matched controls without 
centenarian parents. Furthermore, the study reported that CO 
showed a significant reduction of 62% in all mortality causes 
and a lower risk of 85% for coronary heart disease-specific 
mortality [15]. In addition, median ages of onset for coronary 
heart disease, hypertension, diabetes and stroke were signifi-
cantly delayed in this cohort by 5.0, 2.0, and 8.5 and 8.5 
years, respectively, when compared with age-matched con-
trols [16]. 
 This interesting finding has been subsequently confirmed 
by same researchers [15] that also observed in CO a lower 
risk of 71% in dying cancer when compared with age-
matched controls. This led them to suppose that at younger 
ages (e.g. <70 years), CO have a lower risk for cancer than 
controls. However, they also evidenced that this difference 
disappears as the birth cohort ages and the possible protec-
tive factors remain not clear. Accordingly, Perls and Terry 
suggested in this study that CO may have likely inherited 
genetic variations from their long-lived parents able to pro-
tect them from multiple mutations, thus resulting in lower 
cancer-specific mortality [15].  
 The promising findings of Perls and Terry have been 
confirmed by a recent longitudinal study executed in a group 
of 440 CO, considered to be predisposed to healthy ageing 
[4, 14-18], and 192 control subjects, enrolled and followed 
for over 10 years by the New England Centenarian Study. 
This longitudinal analysis had a specific goal to discern 
whether the differences in the susceptibility for age-related 
diseases between CO and control subjects persist over time 
or disappear, as the two groups get older. During the follow-
up period, CO showed a lower risk of 78% for myocardial 
infarction, of 83% for stroke and of 86% for diabetes melli-
tus than the control cohort. No significant differences were 
observed in onset for other age-related diseases. Addition-
ally, during the follow-up, the CO showed a reduced mortal-
ity equal to 81% than the controls. Thus the authors sug-
gested that CO retain some important cardiovascular advan-
tages over time similarly to their parents. In addition, they 
underlined the concept of longevity family history likely 
determined by physiological causes, since CO have a better 
cardiovascular health and a lower mortality than their peers 
[17].  
 Concordant results have been obtained by Barzilai’s 
group. They demonstrated that CO from Ashkenazi Jewish 
population had a significant lower prevalence for hyperten-
sion (23%), diabetes mellitus (50%), heart attacks (60%) and 
strokes (no events reported) than several age-matched con-
trol groups [4]. 
 In this context, it is also noteworthy to mention the data 
reported by the Long Life Family Study (LLFS) [18], show-
ing in both centenarians and offspring the reduced preva-
lence for diabetes mellitus, chronic pulmonary disease and 
peripheral artery disease than those obtained by both Cardio-
vascular Health Study and Framingham Heart Study cohort 
members [16]. On the other hand, the LLFS study showed 
more optimal measures of both physical function and cardio-
vascular risk factors when compared with the other groups 
[18].  
 This data’s concordance led indentifying the possible 
genetic and molecular pathways able to confer the protective 
cardiovascular profile in CO. Barzilai and colleagues [19, 
20] studied the lipid profiles among Ashkenazi Jewish cen-
tenarians, their children and thechildren’s spouses (the con-
trols in the study). Both male and female children had sig-
nificantly higher high density lipoprotein-cholesterol (HDL-
C) levels when compared with controls and the males also 
had significantly lower low density lipoprotein-cholesterol 
(LDL-C) levels. In order to focus candidate genes of lipopro-
tein metabolism, they also identified a higher frequency of a 
functional variant (homozygosity for the 405 valine) of the 
gene codifying the cholesteryl ester transfer protein (CETP) 
in centenarians and their offspring. This genetic variant in-
creases the particle size of both HDL and LDL [21]. Consis-
tent with this, Li and colleagues [22] also reported a larger 
HDL and LDL protein size in centenarians and their descen-
dants when compared with controls. Newman and colleagues 
[18] found higher HDL-C levels and lower levels of triglyc-
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erides in LLFS centenarians and CO. These features, identi-
fied particularly in CO reflect their protective lipid and car-
diovascular profile. Furthermore, it has been recently evi-
denced a significant correlation between the genetic CETP 
variant and a lower prevalence of hypertension, a reduced 
systolic blood pressure, and a trend toward lower diastolic 
blood pressure [23].  
 In a more recent study, Barzilai’s group genotyped Ash-
kenazi Jewish centenarians (n = 213), their offspring (n = 
216) and an age-matched Ashkenazi control group (n = 258) 
for 66 polymorphisms in 36 genes related to CVD. They 
observed a higher prevalence of homozygosity for the -641C 
(rs2542052) allele inthe APOC3 promoter in centenarians 
(25%) and their offspring (20%) than controls (10%). This 
genotype is associated with significantly lower serum levels 
of APOC3 and a favorable pattern of lipoprotein levels and 
size. A lower prevalence of hypertension and greater insulin-
sensitivity in the -641C homozygotes was found, suggesting 
a protective effect against CVD and metabolic syndrome. 
Homozygosis for the APOC3 -641C allele is associated with 
a favorable lipoprotein profile, cardiovascular health, insulin 
sensitivity and longevity. These data show that genetic 
modulation of lipoproteins may be considered a pathway 
influencing lifespan [24]. 
 In this contest, of interest also are the concordant data on 
lower levels of 70-kd heat shock protein (Hsp70) observed 
by three research groups in centenarians and their offspring. 
Hsp70 is a highly conserved protein having protective and 
deleterious effects [25-27]. It is involved in the pathophysi-
ology of the major age-related diseases, and particularly in 
atherosclerosis and its complications. Usually, its expression 
and release in vascular smooth muscle cells increases under 
oxidative stress induced by risk factors, such as smoking, 
hyperlipidemia, diabetes and hypertension. Thus, circulating 
Hsp70 levels predict the CVD development. In contrast, in 
the individuals achieving an advanced age, Hsp70 shows 
serum lower levels, conferring a beneficial and protective 
effect. In researching to explain the differences in serum 
Hsp70 levels between centenarians, their offspring and age-
matched controls from the New England Centenarian Study 
and the Longevity Genes Project on Ashkenazi Jewish popu-
lation, they were genotyped for two functional tag polymor-
phisms, rs1043618 in HSP70-A1A and rs6457452 in HSP70-
A1B genes. The data obtained demonstrated no associations. 
However, serum Hsp70 levels may be considered as bio-
markers of exceptional longevity [28]. 
 Another possible and key pathway is that of insulin/IGFI. 
In 2007, Cohen and colleagues studied the level of IGFI in 
Ashkenazi Jewish descendants. They showed higher levels 
of this factor related to the control population without a fam-
ily history of longevity. In particular, they found higher se-
rum levels of 35% in female CO respect to age and gender-
matched controls. In contrast, male offspring showed the 
same levels as controls [29].  
 These results suggest that phenotypic and genotypic 
characteristics associated with exceptional longevity are 
transmitted in long lived families. In addition, they empha-
size the importance of cardiovascular health in achieving 
exceptional old age as well as the familial nature of longev-
ity. 
REDUCED RISK FOR ALZHEIMER'S DISEASE AND 
MEMORY DECLINE IN CENTENARIAN OFF-
SPRING  
 With advancing age, individuals can experience cognitive 
decline and develop several forms of dementia. Among 
these, AD represents one of the major health problems, af-
flicting millions of people today [30]. Centenarians are es-
caping and/or postponing this pathology [4, 21, 31]. No con-
sistent data exist on the eventual advantage transmitted from 
centenarians to their offspring to maintain a high physical 
and cognitive function and sustained engagement in social 
and productive activities, and to outlive this disease. Longi-
tudinal studies in CO and offspring of parents with the aver-
age of life expectancy at birth for specific cohorts, using 
rigorous neuropsychological assessments are needed to clar-
ify the influence of parental longevity on cognitive decline.  
 Recently, the Bronx Aging Study [32] provided the op-
portunity to apply this approach. The study enrolled commu-
nity residing subjects (aged 75-85 years) from 1980 to 1983 
and it followed them for 23 years. The study included infor-
mation on parental age at death and extensive annual clini-
cal, neuropsychological and neurological evaluations to de-
termine memory decline and the incidence of dementia dur-
ing follow-up. Using the data from the Bronx Aging Study, 
the Barzilai group tested the hypothesis that parental longev-
ity protects against memory decline and the onset of demen-
tia. Indeed, they demonstrated that CO had a reduced inci-
dence for AD (hazard ratio0.57; 95% CI: 0.35 – 0.93) than 
the control group. In particular, they showed a reduced 
prevalence to develop dementia equal to 36% than the con-
trol group. They also had a significantly reduced rate of 
memory decline on the Selective Reminding Test when com-
pared with the control group [32]. 
 On the other hand, Barraland colleagues [33] observed in 
CO generation from LLFS family members, a better per-
formance on multiple tasks requiring attention, working 
memory and semantic processing when compared with indi-
viduals without a family history of exceptional survival. This 
suggests that cognitive performance may serve as an impor-
tant endophenotype for longevity [33]. Hagberg and Sam-
uelsson [34] also evidenced that hereditary factors, social 
relationships, marital status and personality did not contrib-
ute to survival prediction in this exceptional age group. In 
consequence, in very old age, stochastic determinants may 
dominate over programmed factors (for example family lon-
gevity) in the determining of survival. Yates and colleagues 
[35] found in individuals with more of 90 years a better late-
life physical function (mean ± SD score [maximum 100], 73 
± 23 vs 62 ± 30, p <0.001) and mental well-being (mean 
score, 84 ± 14 vs 81 ± 17, p = 0.03).  
 Based on these observations, CO develops dementia and 
AD at a significantly higher age than controls. This result is 
not explained by demographic or medical confounders. Fac-
tors associated with longevity may protect against dementia 
and AD. 
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IMMUNOLOGICAL HALLMARKS IN CENTENAR-
IAN OFFSPRING 
 The age-related decline of the immune system, which 
accompanies the ageing with several modifications, is called 
immunesenescence [36- 38]. A reduced amount of T, B and 
NK cells is observed in healthy elderly people [39-43]. Fur-
thermore, the T cell compartment shows shrinkage in elderly 
people of a cellular repertoire caused by the filling of the 
immunological space characterized by memory-late differen-
tiated (CD3+CD8+CD45RA-CD27-CD28-) CD8+ T cells 
[44]. Concerning the B cellular compartment, studies did not 
lead to a common consensus. Several contrasting data have 
been suggested on changes occurring in the naive/memory 
subsets. However, a serum increase of switched immuno-
globulins and a reciprocal decrease of both serum IgM and 
IgD have been demonstrated in elderly people [45-47]. This 
last evidence seems to be in agreement with the reduced 
number of naive B cells and the increase of a Double nega-
tive, DN (IgD
-
CD27
-
) IgG
+
 B cell population, observed in 
healthy elderly, as reported by our recent studies [43, 49, 
50]. 
 The interest in establishing the relevance of the immu-
nological features in the centenarian phenotype also led to 
detect several immune parameters [47, 50-54]. Therefore, it 
has been suggested that centenarians share some typical im-
munological parameters of young people and others charac-
teristic of the elderly. Among these, the number of NK cells 
and their activity in centenarians are well conserved and 
comparable to those observed in young people, when com-
pared with elderly people. In contrast, a decrease in B lym-
phocytes and naive T cells, a progressive increase of CD28-
cytotoxic T cells, the expansion of clones of memory T cells, 
a shrinkage of the T cell repertoire characterise the cente-
narians, are typical changes of immunosenescence. Further-
more, they have no organ-specific auto-antibodies, often 
observed in healthy elderly individuals, and they present 
some signs of inflammation, including high plasma levels of 
pro-inflammatory cytokines, i.e. IL-6 and a lipoprotein, 
Lp(a), considered a CVD risk factor and genetically con-
trolled, as well as coagulation factors [36, 37, 52, 55-57]. 
 Siblings and offspring of long lived subjects, as described 
above, also represent a good model to analyse the immune 
profile and consequently to understand the advantages of 
centenarian phenotype [25, 58-60]. Until now, the literature 
has reported only on some aspects of the CO immune profile, 
i.e. data about the B cell branch. In this context, our recent 
data are of interest. Comparing the B cells from individuals 
of different age groups (young, elderly and CO), we noted 
that B cells from CO are more comparable to those from 
young people, when compared with those from healthy old 
subjects. Like young individuals, CO is characterised, in-
deed, by an increase of naïve (IgD
+
CD27
-
) B cells [61]. This 
is a remarkable observation, since the bone marrow ability to 
generate B cells is impaired with age [61]. Furthermore, our 
comparative analysis revealed that CO also has a decrease in 
percentage of DN B cells [43]. The analysis of serum IgM 
concentration in CO also revealed the presence of higher 
levels in CO than their controls. Our supposition is that CO 
behaves as the young individuals. This might allow them to 
preserve themselves from new infections and to respond to 
vaccinations. All together, these data might be related to 
their healthier ageing [62]. 
ROLE OF VARIATIONS IN HUMAN TELOMERASE 
GENE AND MITOCONDRIAL DNA  
 A close relation between telomere length and life span in 
humans, including long lived humans, has been reported 
[63]. However, interpretations of results are often con-
founded because of a lack of adequate controls [64, 65]. Re-
cently, the group of Barzilai employed an unique study de-
sign to overcome this inadequacy in a cohort of Ashkenazi 
Jewish individuals with exceptional longevity (centenarians), 
their offspring (approximate age of 70 years), and age- and 
gender-matched controls without a family history of longev-
ity. Using this study’s approach, the potential associations 
between telomere length and longevity, and age-related dis-
eases have been investigated. Furthermore, the potential role 
of genetic variations in human telomerase reverse tran-
scriptase (hTERT) and human telomerase RNA component 
(hTERC) genes in the better maintenance of telomere length 
in the centenarians and their CO has been also assessed [66].  
 The Barzilai’s group demonstrated significantly longer 
telomeres in centenarians and their offspring than the con-
trols [66]. In addition, CO did not show an appreciable age-
related decline in telomere length as observed using unre-
lated controls or in cross-sectional studies [66]. 
 Because shorter telomere length is associated with age-
related disease, including hypertension, metabolic syndrome 
and dementia, the authors also analyzed the association be-
tween telomere length, the major age-related diseases and 
lipid profiles in centenarians, their offspring and controls 
[64, 65, 67]. They observed that longer telomeres are indeed 
associated with lower prevalence of hypertension, metabolic 
syndrome, type 2 diabetes mellitus and a better cognitive 
function, as well as with healthier lipid profiles. In addition, 
they reported that two synonymous (973 G > A (Ala-305 
Ala) and 3097 C > T (His-1013 His)) and two intronic vari-
ants (IVS1–187 T > C andIVS16+99 C > T) and their haplo-
types in hTERT gene are enriched in centenarians when 
compared with controls. These variants are known to play a 
functional role in the regulation of gene expression through 
modulation of mRNA stability, mRNA secondary structure, 
alternative splicing or translational efficiency [66]. Thus, the 
telomerase genes may function as important genetic determi-
nants of both human longevity and telomere length. Addi-
tionally, these data suggest that both telomere length and 
variants of telomerase genes may have a cumulative influ-
ence on lower disease prevalence and a favorable lipid pro-
file in centenarians and their offspring [66, 67]. 
 Mitochondrial DNA (mtDNA) is another important tool 
to understand longevity [68]. It encodes for 2rRNA, 22 
tRNA and 13 polypeptides that take part to oxidative phos-
phorylation process [69]. It produces reactive oxygen spe-
cies potentially dangerous for the mitochondrion itself [69]. 
It does not present non coding region except one, the D-
loop, containing binding sites for the replication and tran-
scription [69]. Iwata and colleagues [69] published a paper 
about mtDNAmutations in Askhenazi Jews. In particular, 
blood leukocyte samples of mixed gender offspring and 
non-maternally related controls were analyzed to confirm 
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the role of the C150T transition in longevity. This variant 
occurs in one of heavy chain replication origins shifting 
this origin from position 151 to 149. The Iwata’s group 
observed that this genetic variant is more frequently ex-
pressed in Italian centenarians [69]. No association of this 
variant with longevity has been confirmed in Askhenazi 
population [69]. Thus, these data suggest that this genetic 
variant is population-dependent, as shown in some popula-
tions, including Finnish and Japanese populations [69]. In 
contrast, an ageing-related raise of the heteroplasmic 
T152C transition frequency has been observed. However, 
other studies will be useful to confirm the role of these mu-
tations in longevity [69].  
CONCLUSION 
 In these last years, the gerontologists have focused their 
efforts in identifying a correct study model to understand the 
characteristics of successful ageing. CO seems to represent 
the appropriate model to analyze successful ageing. They 
show a favorable lipid, immunological and cardiovascular 
profile, a decreased cognitive decline and a protective ge-
netic background (Table 1).  
 Lower serum levels of APOC3, Hsp70 and LDL-C, and 
higher amount of HDL-C characterize their lipid and cardio-
vascular profile [18-22, 24-28]. Cardiovascular health con-
sents them to escape morbidity and mortality for adverse 
Table 1. Molecular and phenotypical features of CO. 
Lipid and Cardiovascular Profile Changes References 
Serum level of APOC3 Decrease [24] 
Serum level HSP70 Decrease [25-28] 
Level and larger size LDL-C Decrease [18-22] 
Level and larger size HDL-C Increased [18-22] 
Risk for hypertension Decrease [4, 14-18] 
Risk for type II diabetes Decrease [4, 14-18] 
Risk of stroke Decrease [4, 14-18] 
Risk myocardial infarction Decrease [4, 14-18] 
Coronary heart disease Decrease [4, 14-18] 
Cognitive Profile Changes References 
Development of dementia Reduced [21, 32-35] 
Development of Alzheimer’s disease Reduced [4, 21] 
Favorable Immunological Profile Changes References 
Naïve T cells (CD3+CD8+CD45RA+CCR7+CD27+CD28+) Increase [43] 
Late differentiated effector memory T cells (CD3+CD8+CD45RA-CCR7- CD27-CD28-) Decrease [43] 
TEMRA (CD3+CD8+CD45RA+CCR7-CD27-CD28-) Decrease [43] 
Naïve B cells (IgD+CD27-) Increase [44] 
Double Negative B cells (IgG+/IgA+IgD-CD27-) Decrease [44] 
Serum IgM Increase [44] 
Genetic Profile Changes References 
Homozygosis for the -641C (rs2542052) allele inthe APOC3 promoter Increase [24] 
Homozygosis for the 405 valine of CEPT Increase [19-21, 23] 
Telomere attrition Decrease [66] 
Presence of synonymous andintronic variants in h-TERT gene Increase [66] 
Heteroplasmic T152C variant in mt-DNA Increase [69] 
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cardiac events, including atherothrombosis, myocardial in-
farction, stroke and heart failure. The CVDs represent the 
first cause of death in Western countries. This condition im-
plies serious social, medical and economic problems, as hos-
pitalization and assistance of not autonomous and invalid 
individuals, and the existence of no appropriate therapies.  
 Furthermore, CO seems to show an optimal immune con-
trol. They, like their parents, present a immunological profile 
which is comparable for several aspects, i.e. number and 
activity of NK cells and B compartment, to that of young 
individuals [43, 44]. Thus, CO behaves as the young people, 
counteracting new infections and responding to vaccinations. 
At the same time, this condition determines an adequate con-
trol of inflammatory response, and as consequence a con-
comitant reduction of the risk for the major age-related dis-
eases.  
 In addition, CO maintain a high physical and cognitive 
function, and a sustained engagement in social and produc-
tive activities, and they outlive several dementia forms, such 
as AD [4, 21, 32-35]. 
 Another feature of CO is to have an advantageous genetic 
background characterized by homozygosity for the -641C 
(rs2542052) allele inthe APOC3 promoter, homozygosity for 
the 405 valine of CEPT, reduced telomere attrition associ-
ated with the presence of synonymous andintronic variants in 
h-TERT gene, and heteroplasmic T152C variant in mt-DNA 
[19-21, 23, 24, 66, 69].  
 The concomitant action of all factors described suggests 
that the positive ageing phenotype might be the result of an 
efficient physical performance, rather than an avoidance of 
death. This allows them to have a major chance to extend 
survival in health and well-being.  
 However, other studies are needed to confirm and extend 
these current data. For example, genomic, transcriptomic and 
epigenetic investigations may eventually lead to better un-
derstanding the molecular and cellular mechanisms associ-
ated with successful ageing. On the other hand, the first epi-
genetic data obtained by the group of Gentilini seem to be 
promising [70]. They recently demonstrated that a better 
preservation of DNA methylation status, a slower cell grow-
ing/metabolism, and a better control in signal transmission 
through epigenetic mechanisms may be involved in the proc-
ess of human longevity [70].  
 In this future and perspective way of research, it could 
also be interesting to evaluate the protective role of TERT on 
mitochondria. It has been recently evidenced that mitochon-
drial TERT protects mitochondrial DNA and function from 
damage [71, 72]. This relatively new research area could be 
crucial to better understand the cross talk between nucleus 
and mitochondria and its age-related changes, including the 
possible impact on successful ageing. 
 Furthermore, these investigations might also consent 
likely to understand the biologic gender effect on longevity. 
A characteristic enigma of longevity is, indeed, the gender 
and the social phenomenon of “feminization of old age”. The 
demographic and social changes of the past decades, respon-
sible for longevity and the improvements in public health, 
have created new and often very dissimilar realties for 
women and men. They differ not only in their anatomy and 
physiology, but also in more complex traits, such as lifespan 
(in Italy, 78.8 years for men and 84.1 years for women, re-
spectively) and mortality [73]. No conclusive explanation for 
these new differences is actually demonstrated. However, the 
group of Gentilini has recently investigated the role of age-
related X chromosome inactivation (XCI) skewing in the 
lifespan of women. The data obtained showed that age-
dependent skewing of XCI appears delayed in centenarians' 
offspring [74].  
  These study approach might permit the identification of 
targets to use as possible successful ageing biomarkers. Fur-
thermore, it might consent to develop anti-ageing therapies, 
modulating ageing rate, developing drugs (i.e. antioxidants) 
or new lifestyle habits (i.e. a healthy diet, caloric uptake re-
duction, use of prebiotics and probiotics and increased 
physical exercise).  
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